Aeglea BioTherapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
Aeglea BioTherapeutics (AGLE) IPO Opens Flat
April 7, 2016 10:55 AM EDTToday's IPO for Aeglea BioTherapeutics (NASDQ: AGLE) opened for trading at $10 after pricing 5,000,000 shares of its common stock at an initial public offering price of $10 per share.
UBS Investment Bank, BMO Capital Markets and Wells Fargo Securities are acting as joint book-running managers... More



